Characterization of Digoxin‐Like Materials in Human Cord Serum

Human cord serum contains substantial amounts of materials that cross-react in radioimmunoassays for digoxin. The average content of digoxin-like immunoreactivity in mixed cord serum is 0.3 +/- 0.05 ngE/ml compared to less than 0.05 ngE/ml in serum from normal adults. After solvent extraction, the major digoxin-like materials present in cord serum coelute on Sephadex LH-20 column with the steroid sulfate fraction. The steroid sulfates are digoxin-like materials because they cross-react in the digoxin RIA. If the amount of dehydroepiandrosterone sulfate, 16 alpha-hydroxydehydroepiandrosterone sulfate, and 15 beta-hydroxydehydroepiandrosterone sulfate present in cord serum and the amount of digoxin-like material present in the same serum are considered, then up to 90% of the digoxin-like materials present can be accounted for on the basis of the steroid sulfates present. However, although steroid sulfates contribute to the digoxin immunoreactivity in both serum and breast cyst fluid, digoxin-like materials are present in breast cyst fluid that are not present in cord serum.

[1]  H. Bradlow,et al.  Digoxinlike Materials in Human Breast Cyst Fluids , 1990, Annals of the New York Academy of Sciences.

[2]  M. H. Gault,et al.  Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients. , 1987, Clinical nephrology.

[3]  T. M. Runge.  Clinical pharmacology of digitalis glycosides. , 1986, American heart journal.

[4]  A. Doucet,et al.  Evidence for differences in the sensitivity to ouabain of NaK-ATPase along the nephrons of rabbit kidney. , 1986, The Journal of biological chemistry.

[5]  K. Taysi,et al.  Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents , 1985, Steroids.

[6]  M. H. Gault,et al.  Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults. , 1985, Research communications in chemical pathology and pharmacology.

[7]  S. Blethen,et al.  17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. , 1985, The Journal of clinical endocrinology and metabolism.

[8]  A. Nanji,et al.  Falsely raised plasma digoxin concentrations in liver disease. , 1985, British medical journal.

[9]  S. Blethen,et al.  Dehydroepiandrosterone (DHEA) measurements in cord blood , 1985, Steroids.

[10]  F. LaBella.  Endogenous digitalis-like factors. Introductory remarks. , 1985, Federation proceedings.

[11]  M. Whitfield,et al.  Perinatal Changes in a Digoxin-like Immunoreactive Substance , 1984, Pediatric Research.

[12]  M. Whitfield,et al.  Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. , 1983, The New England journal of medicine.

[13]  I. Grupp,et al.  MECHANISM OF ACTION OF DIGITALIS: IS THE Na, K‐ATPase THE PHARMACOLOGICAL RECEPTOR? , 1982, Annals of the New York Academy of Sciences.

[14]  J. Morley.  The endocrinology of the opiates and opioid peptides. , 1981, Metabolism: clinical and experimental.

[15]  F. Gray.  BASIC AND CLINICAL PHARMACOLOGY OF DIGITALIS , 1974 .

[16]  B. Roth-Schechter,et al.  Dissociation of the positive inotropic action of digitalis from inhibition of sodium- and potassium-activated adenosine triphosphate. , 1973, The Journal of pharmacology and experimental therapeutics.

[17]  E. Haber,et al.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. , 1969, The New England journal of medicine.

[18]  J. P. Chen,et al.  Digoxin-specific antibodies. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. S. Rgyl.  Chemical Physiology of Contraction in Body and Heart Muscle , 1954 .

[20]  A. Szent-Györgyi.  Chemical physiology of contraction in body and heart muscle , 1953 .